The first blood test to help diagnose Alzheimer’s disease will be available from late June in the US following regulatory ...

A dementia-focused transatlantic venture capital initiative has secured $269 million in commitments for its second fund. | A ...

In the Phase 2 study of patients with chronic kidney disease, the highest dose of the drug lowered by 86% the levels of ...